The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Caregivers for people with dementia are more likely to report having at least one modifiable risk factor linked to developing dementia.

The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

Automated data review assists in identifying problematic opioid usage, outperforming manual methods in sensitivity and positive predictive value.

Mortality rates associated with calciphylaxis are lower than previously observed, with rates of 28.88% at 1-year and 29.92% at 2-years.

Rates of proven drug hypersensitivity reactions are comparable between children with and without inborn errors of immunity (IEI).

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.